Having graduated from Miami University with a Bachelor of Science situated in Ohio, he has made quite a mark in his career. Marc Beer has delved deeper in the sphere of where technology meets medicine, and this has widely been seen by his indulgence in making wherever company he has been to achieve success, growth and development, a clear indication that not only is he a good leader but the captain of industries in the MedTech industry.
On the list of successful entrepreneurs, Marc Beer is on top of it. Recently has been made major news. He has held various positions in the Board of Directors. Genzyme has had Marc Beer as the Vice President of Global Marketing. His major role was being in charge of the launch of the company’s products. He has served in many capacities some of them including sales and marketing executive, Chairman and a member of the Board of directors among other envious positions.
Marc Beer CEO and Co-Founder of started Renovia in August 2016 and is the current chairman. With only two years in the industry, it has made impacts. The medical technology is based in Boston, and it helps in creating a difference in people lives by creating devices that help combat pelvic floor disorders. He founded the company with Ramon Iglesias, Yolanda Lorie. His field of expertise is majorly inclined towards the healthcare funding business.
Marc Beer has had many work experiences in companies such as ViaCell, a biotechnology company. Under Marc Beer, the company had led a rapid growth with over 300 workers and their specialization if the collection, development, and preservation of the stem cells in the body.
With an over 25 years of experience in the commercialization industry of biotechnology, diagnostic industries as well as the pharmaceuticals, Marc Beer has just had a signed deal that is geared towards raising 42 million dollars to help fund a start-up for women health in Renovia Inc. The 42 million dollar funding is considered the B series by Marc Beer and the Renovia company as they have become interested in developing technology that helps women experiencing pelvic disorders floor. This will be done by developing the pelvic disorders treating methods by innovative technology uses.
This comes shortly after the Series A funding was used in acquiring another equity for the company. Renovia under Marc Beer has its work geared to bringing new products to the market and thriving in medicine. However, Marc Beer and his team not only have put interest in this major development but also part of the funding has been set aside for the following: Learn more: https://www.benzinga.com/pressreleases/18/08/r12237847/osf-ventures-invests-in-company-developing-solutions-for-pelvic-floor-
- Commercial launches and marketing launches
- Product improvement and development
- Clinical trials for the future